Movatterモバイル変換

[0]ホーム
URL:

SE9301911D0 - NEW PEPTIDE DERIVATIVES - Google Patents

NEW PEPTIDE DERIVATIVES

Info

Publication number
SE9301911D0
SE9301911D0SE19939301911ASE9301911ASE9301911D0SE 9301911 D0SE9301911 D0SE 9301911D0SE 19939301911 ASE19939301911 ASE 19939301911ASE 9301911 ASE9301911 ASE 9301911ASE 9301911 D0SE9301911 D0SE 9301911D0
Authority
SE
Sweden
Prior art keywords
peptide derivatives
new peptide
structural fragment
iie
iid
Prior art date
Application number
SE19939301911A
Other languages
Swedish (sv)
Inventor
Thomas *Antonsson Karl
Elvy *Bylund Ruth
Original Assignee
Ab Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ab AstrafiledCriticalAb Astra
Priority to SE19939301911ApriorityCriticalpatent/SE9301911D0/en
Publication of SE9301911D0publicationCriticalpatent/SE9301911D0/en
Priority to AU69408/94Aprioritypatent/AU685465B2/en
Priority to EP94917871Aprioritypatent/EP0701567A1/en
Priority to JP7501664Aprioritypatent/JPH08511017A/en
Priority to PCT/SE1994/000534prioritypatent/WO1994029335A1/en

Links

Classifications

Landscapes

Abstract

A compound of the general formula (I): A<1> - A<2> -NH-(CH2)n - NH-C(NH)-NH2, wherein n is an integer 2, 3, 4, 5, or 6; preferably 3 or 4; A<1> represents a structural fragment of formulae (IIa), (IIb), (IIc), (IId) or (IIe); A<2> represents a structural fragment (a), as well as processes for the preparation thereof, the use and the pharmaceutical formulations.
SE19939301911A1993-06-031993-06-03 NEW PEPTIDE DERIVATIVESSE9301911D0 (en)

Priority Applications (5)

Application NumberPriority DateFiling DateTitle
SE19939301911ASE9301911D0 (en)1993-06-031993-06-03 NEW PEPTIDE DERIVATIVES
AU69408/94AAU685465B2 (en)1993-06-031994-06-02New peptides derivatives
EP94917871AEP0701567A1 (en)1993-06-031994-06-02New peptides derivatives
JP7501664AJPH08511017A (en)1993-06-031994-06-02 New peptide derivatives
PCT/SE1994/000534WO1994029335A1 (en)1993-06-031994-06-02New peptides derivatives

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
SE19939301911ASE9301911D0 (en)1993-06-031993-06-03 NEW PEPTIDE DERIVATIVES

Publications (1)

Publication NumberPublication Date
SE9301911D0true SE9301911D0 (en)1993-06-03

Family

ID=20390161

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SE19939301911ASE9301911D0 (en)1993-06-031993-06-03 NEW PEPTIDE DERIVATIVES

Country Status (5)

CountryLink
EP (1)EP0701567A1 (en)
JP (1)JPH08511017A (en)
AU (1)AU685465B2 (en)
SE (1)SE9301911D0 (en)
WO (1)WO1994029335A1 (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6825169B1 (en)1991-10-222004-11-30Trustees Of Tufts CollegeInhibitors of dipeptidyl-aminopeptidase type IV
US5705487A (en)*1994-03-041998-01-06Eli Lilly And CompanyAntithrombotic agents
US5726159A (en)*1994-03-041998-03-10Eli Lilly And CompanyAntithrombotic agents
ZA951618B (en)*1994-03-041996-08-27Lilly Co EliAntithrombotic agents
US5885967A (en)*1994-03-041999-03-23Eli Lilly And CompanyAntithrombotic agents
CA2143533A1 (en)*1994-03-041995-09-05Kenneth D. KurzAntithrombotic agents
US5602101A (en)*1994-03-041997-02-11Eli Lilly And CompanyAntithrombotic agents
US5914319A (en)*1995-02-271999-06-22Eli Lilly And CompanyAntithrombotic agents
US5710130A (en)*1995-02-271998-01-20Eli Lilly And CompanyAntithrombotic agents
US5614198A (en)*1995-07-251997-03-25The Trustees Of The University Of PennsylvaniaBowman-Birk Inhibitor compositions for treatment of inflammatory disease
US5965532A (en)1996-06-281999-10-12Trustees Of Tufts CollegeMultivalent compounds for crosslinking receptors and uses thereof
US6100234A (en)1997-05-072000-08-08Tufts UniversityTreatment of HIV
US6040145A (en)1997-05-072000-03-21Tufts UniversityPotentiation of the immune response
US6258597B1 (en)1997-09-292001-07-10Point Therapeutics, Inc.Stimulation of hematopoietic cells in vitro
TWI252107B (en)1998-05-042006-04-01Piint Therapeutics IncPharmaceutical compositions and kits for hematopoietic usage
PT1084129E (en)1998-06-052003-06-30Point Therapeutics Inc BOROPROLINE CYCLIC COMPOUNDS
US6979697B1 (en)1998-08-212005-12-27Point Therapeutics, Inc.Regulation of substrate activity
US6890904B1 (en)1999-05-252005-05-10Point Therapeutics, Inc.Anti-tumor agents
GB0205527D0 (en)*2002-03-082002-04-24Ferring BvInhibitors
EP1736465A4 (en)2004-03-312009-06-17Ajinomoto KkAniline derivatives
GB0918924D0 (en)2009-10-282009-12-16Vantia LtdAzaindole derivatives
GB0918922D0 (en)2009-10-282009-12-16Vantia LtdAminopyridine derivatives
GB0918923D0 (en)2009-10-282009-12-16Vantia LtdAminothiazole derivatives
GB2494851A (en)2011-07-072013-03-27Kalvista Pharmaceuticals LtdPlasma kallikrein inhibitors
GB201212081D0 (en)2012-07-062012-08-22Kalvista Pharmaceuticals LtdNew polymorph
GB201300304D0 (en)2013-01-082013-02-20Kalvista Pharmaceuticals LtdBenzylamine derivatives
PH12015501492A1 (en)2013-01-082015-09-28Kalvista Pharmaceuticals LtdBenzylamine derivatives
GB2510407A (en)*2013-02-042014-08-06Kalvista Pharmaceuticals LtdAqueous suspensions of kallikrein inhibitors for parenteral administration
SI3305778T1 (en)2013-05-232022-04-29Kalvista Pharmaceuticals LimitedInhibitors of plasma kallikrein
JP6527147B2 (en)2013-08-142019-06-05カルヴィスタ ファーマシューティカルズ リミテッド Inhibitors of plasma kallikrein
GB2517908A (en)2013-08-142015-03-11Kalvista Pharmaceuticals LtdBicyclic inhibitors
TWI636047B (en)2013-08-142018-09-21英商卡爾維斯塔製藥有限公司Heterocyclic derivatives
GB201421083D0 (en)2014-11-272015-01-14Kalvista Pharmaceuticals LtdEnzyme inhibitors
GB201421085D0 (en)2014-11-272015-01-14Kalvista Pharmaceuticals LtdNew enzyme inhibitors
GB201421088D0 (en)2014-11-272015-01-14Kalvista Pharmaceuticals LtdNew enzyme inhibitors
JP6884801B2 (en)2016-05-312021-06-09カルビスタ・ファーマシューティカルズ・リミテッド Pyrazole derivative as plasma kallikrein inhibitor
GB201609607D0 (en)2016-06-012016-07-13Kalvista Pharmaceuticals LtdPolymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201609603D0 (en)2016-06-012016-07-13Kalvista Pharmaceuticals LtdPolymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide
HRP20220367T1 (en)2017-11-292022-05-27Kalvista Pharmaceuticals LimitedDosage forms comprising a plasma kallikrein inhibitor
GB201719881D0 (en)2017-11-292018-01-10Kalvista Pharmaceuticals LtdSolid forms of plasma kallikrein inhibitor and salts thereof
US11584714B2 (en)2018-05-292023-02-21Omeros CorporationMASP-2 inhibitors and methods of use
AU2019277150B2 (en)2018-05-292023-08-24Omeros CorporationMASP-2 inhibitors and methods of use
GB201910125D0 (en)2019-07-152019-08-28Kalvista Pharmaceuticals LtdTreatments of angioedema
GB201910116D0 (en)2019-07-152019-08-28Kalvista Pharmaceuticals LtdTreatments of hereditary angioedema
WO2021028645A1 (en)2019-08-092021-02-18Kalvista Pharmaceuticals LimitedPlasma kallikrein inhibitors
CA3159172A1 (en)2019-12-042021-06-10Michael CicirelliMasp-2 inhibitors and methods of use
JP2023504541A (en)2019-12-042023-02-03オメロス コーポレーション MASP-2 inhibitors and methods of use
US12110288B2 (en)2019-12-042024-10-08Omeros CorporationMASP-2 inhibitors and methods of use
GB2591730A (en)2019-12-092021-08-11Kalvista Pharmaceuticals LtdNew polymorphs
GB201918994D0 (en)2019-12-202020-02-05Kalvista Pharmaceuticals LtdTreatments of diabetic macular edema and impaired visual acuity
TW202228686A (en)2020-10-152022-08-01英商卡爾維斯塔製藥有限公司Treatments of angioedema
EP4232031A1 (en)2020-10-232023-08-30Kalvista Pharmaceuticals LimitedTreatments of angioedema
EP4291186A1 (en)2021-02-092023-12-20Kalvista Pharmaceuticals LimitedTreatments of hereditary angioedema
WO2023002219A1 (en)2021-07-232023-01-26Kalvista Pharmaceuticals LimitedTreatments of hereditary angioedema
CN119095589A (en)2022-04-272024-12-06卡尔维斯塔制药有限公司Formulations of plasma kallikrein inhibitors
WO2024180100A1 (en)2023-02-272024-09-06Kalvista Pharmaceuticals LimitedNew solid form of a plasma kallikrein inhibitor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
HU178398B (en)*1979-06-121982-04-28Gyogyszerkutato IntezetProcess for producing new agmatine derivatives of activity against haemagglutination
GB9019558D0 (en)*1990-09-071990-10-24Szelke MichaelEnzyme inhibitors

Also Published As

Publication numberPublication date
AU685465B2 (en)1998-01-22
JPH08511017A (en)1996-11-19
WO1994029335A1 (en)1994-12-22
EP0701567A1 (en)1996-03-20
AU6940894A (en)1995-01-03

Similar Documents

PublicationPublication DateTitle
SE9301911D0 (en) NEW PEPTIDE DERIVATIVES
SE9103572D0 (en) ORGANIC SALTS OF N, N&#39;-DIACETYL CYSTINE
TR199902593T2 (en) Substituted phenyl derivatives, their preparation and use.
TR199700844T1 (en) Pyrazolyl-Benzoil T�revleri.
IL126610A0 (en)N-(amidinophenyl)-n&#39;-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors
DK0934950T3 (en) tetrapeptide
TW336939B (en)Lipopeptide derivatives, a process for their preparation and their use
BR8906791A (en) INSECTICIDE COMPOSITION; GUANIDINE DERIVATIVE AND PROCESS FOR ITS PREPARATION
DE122004000045I2 (en) NOVEL PEPTIDE DERIVATIVES
AU8772691A (en)New compounds
RU94036004A (en)Intermediate compounds for preparing aromatic aminoalcoholic derivatives
BR0210078A (en) Compound, use thereof, and pharmaceutical formulation
CA2118812A1 (en)5-ht4 receptor antagonists
AU5901490A (en)Hemoregulatory peptides
RU94046387A (en)Derivatives of pyrimidine, method of their synthesis, pharmaceutical composition, its use and intermediate compounds
EP0667163A4 (en)Powder for nasal administration of peptidic or proteinaceous drug
DE68912438D1 (en) Antifungal antibiotics.
YU48915B (en) SULFONYLCARBAMIDE AND PROCEDURE FOR ITS PRODUCTION
DK0888379T3 (en) Compounds of the amidinium family, pharmaceutical compositions containing these compounds and their use
RU94014631A (en)4-quinolyldihydropyridine derivatives, mixture of isomers thereof or individual isomers salts thereof
DE69423339D1 (en) EPOXYCYCLOHEXENDION DERIVATIVE
ATE282608T1 (en) QUINOXALINDIONES
FI930092A0 (en) INDANOPYRROLIDINKARBAMATER
EA199900684A1 (en) Iminoazanthracyclinone derivatives for the treatment of amyloidosis
ATE104315T1 (en) PEPTIDE DERIVATIVES AND AGENTS AGAINST DEMENTIA.
[8]ページ先頭
©2009-2025 Movatter.jp